BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37056334)

  • 1. Erratum: Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines.
    Frontiers Production Office
    Front Oncol; 2023; 13():1190120. PubMed ID: 37056334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines.
    Canevarolo RR; Melo CPS; Cury NM; Artico LL; Corrêa JR; Tonhasca Lau Y; Mariano SS; Sudalagunta PR; Brandalise SR; Zeri ACM; Yunes JA
    Front Oncol; 2022; 12():1032336. PubMed ID: 36531023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell lines.
    Efferth T; Verdorfer I; Miyachi H; Sauerbrey A; Drexler HG; Chitambar CR; Haber M; Gebhart E
    Blood Cells Mol Dis; 2002; 29(1):1-13. PubMed ID: 12482398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Patient-specific assays based on whole-genome sequencing data to measure residual disease in children with acute lymphoblastic leukemia: A proof of concept study.
    Frontiers Production Office
    Front Oncol; 2022; 12():1124071. PubMed ID: 36686724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.
    Matherly LH; Taub JW; Ravindranath Y; Proefke SA; Wong SC; Gimotty P; Buck S; Wright JE; Rosowsky A
    Blood; 1995 Jan; 85(2):500-9. PubMed ID: 7812005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition factors of arsenic trioxide therapeutic effects in patients with acute promyelocytic leukemia.
    Sui M; Zhang Z; Zhou J
    Chin Med J (Engl); 2014; 127(19):3503-6. PubMed ID: 25269921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic-induced apoptosis in malignant cells in vitro.
    Akao Y; Yamada H; Nakagawa Y
    Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.
    Ongaro A; De Mattei M; Della Porta MG; Rigolin G; Ambrosio C; Di Raimondo F; Pellati A; Masieri FF; Caruso A; Catozzi L; Gemmati D
    Haematologica; 2009 Oct; 94(10):1391-8. PubMed ID: 19648163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cellular glutathione and protection by bone marrow stromal cells account for the resistance of non-acute promylocytic leukemia acute myeloid leukemia cells to arsenic trioxide in vivo.
    Lee C; Lin Y; Huang M; Lin C; Liu C; Chow J; Liu HE
    Leuk Lymphoma; 2006 Mar; 47(3):521-9. PubMed ID: 16396776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
    Seo T; Urasaki Y; Takemura H; Ueda T
    Anticancer Res; 2005; 25(2A):991-8. PubMed ID: 15868938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between the activities of 19 standard anticancer agents, antioxidative enzyme activities and the expression of ATP-binding cassette transporters: comparison with the National Cancer Institute data.
    Bracht K; Liebeke M; Ritter CA; Grünert R; Bednarski PJ
    Anticancer Drugs; 2007 Apr; 18(4):389-404. PubMed ID: 17351391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro.
    Ohnuma T; Lo RJ; Scanlon KJ; Kamen BA; Ohnoshi T; Wolman SR; Holland JF
    Cancer Res; 1985 Apr; 45(4):1815-22. PubMed ID: 3856477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations.
    Göker E; Waltham M; Kheradpour A; Trippett T; Mazumdar M; Elisseyeff Y; Schnieders B; Steinherz P; Tan C; Berman E
    Blood; 1995 Jul; 86(2):677-84. PubMed ID: 7605998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of -24CT, 1249GA, and 3972CT ABCC2 gene polymorphisms with methotrexate serum levels and toxic side effects in children with acute lymphoblastic leukemia.
    Sharifi MJ; Bahoush G; Zaker F; Ansari S; Rafsanjani KA; Sharafi H
    Pediatr Hematol Oncol; 2014 Mar; 31(2):169-77. PubMed ID: 24552501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2 activation ameliorates cytotoxic effects of arsenic trioxide in acute promyelocytic leukemia cells through increased glutathione levels and arsenic efflux from cells.
    Nishimoto S; Suzuki T; Koike S; Yuan B; Takagi N; Ogasawara Y
    Toxicol Appl Pharmacol; 2016 Aug; 305():161-168. PubMed ID: 27317373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential methotrexate resistance in childhood T- versus common/preB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay.
    Rots MG; Pieters R; Kaspers GJ; van Zantwijk CH; Noordhuis P; Mauritz R; Veerman AJ; Jansen G; Peters GJ
    Blood; 1999 Feb; 93(3):1067-74. PubMed ID: 9920857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia.
    Buitenkamp TD; Mathôt RA; de Haas V; Pieters R; Zwaan CM
    Haematologica; 2010 Jul; 95(7):1106-13. PubMed ID: 20418240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia.
    Matherly LH; Taub JW
    Leuk Lymphoma; 1996 May; 21(5-6):359-68. PubMed ID: 9172800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose methotrexate-related pneumonitis in a child with acute lymphoblastic leukemia.
    Rakez R; Boufrikha W; Cheffaï A; Boukhriss S; Laatiri MA
    J Oncol Pharm Pract; 2023 Mar; 29(2):506-510. PubMed ID: 35854419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: a pilot prognostic factor analysis.
    Whitehead VM; Rosenblatt DS; Vuchich MJ; Shuster JJ; Witte A; Beaulieu D
    Blood; 1990 Jul; 76(1):44-9. PubMed ID: 1694703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.